• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors



Anju Sahay, PhD

Latest:

Patient Ratings of Veterans Affairs and Affiliated Hospitals

The mean online patient rating for Veterans Affairs hospitals was higher (3.70 ± 1.3 out of 5) than the rating for affiliated hospitals (3.19 ± 1.3; P = .003).


Deborah Lubeck, PhD

Latest:

Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost

Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.


Patrick T. Tyree, AA

Latest:

Complementary and Alternative Medicine Provider Use and Expenditures by Cancer Treatment Phase

More than 26% of cancer patients see CAM providers, primarily for musculoskeletal problems; use does not vary by treatment phase, and associated expenditures are low.



Sara Karlovitch

Latest:

Rates of Thrombosis in Patients Treated With Hydroxyurea Fairly Stable Over Time, Review Finds

Mortality and myelofibrosis varied depending on follow-up duration in this review of patients with polycythemia vera treated with hydroxyurea, and incidences of thrombosis and acute myeloid leukemia (AML) were stable over time.


Barbara G. Silverman, MD, MPH

Latest:

Can a Nationwide Media Campaign Affect Antibiotic Use?

A nationwide media campaign aimed at parents was associated with reductions in the use of antibiotics for pediatric upper respiratory infections, otitis media, and pharyngitis.


Amy Bruce, MPP

Latest:

Project ECHO: An Effective Means of Increasing Palliative Care Capacity

This article provides insight on the work of 7 of Project ECHO’s replicating partners from around the world who are implementing the ECHO model to address the knowledge gap that underlies integrated palliative care crisis.



Karen G. Schmidt, MPH

Latest:

Effect of a Managed Care Disease Management Program on Diabetes Care

Processes and outcomes of diabetes care improved substantially over 6 years in a managed care health plan with a comprehensive diabetes disease management program.


Kenneth J. Sklar, EdD

Latest:

Assessing Outcomes in Child Psychiatry

Two standardized rating scales appeared to be valid and reliable for use at admission and possibly follow-up in a child psychiatry system of care.













Piia T. Lavikainen, MSc

Latest:

Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide Study

One-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.





Robert Wellman, MS

Latest:

Decision Aids for Benign Prostatic Hyperplasia and Prostate Cancer

Implementing patient decision aids was associated with lower rates of elective surgery for benign prostatic hyperplasia and of active treatment for localized prostate cancer.


Anna D. Coutinho, PhD

Latest:

Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT

This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.



© 2025 MJH Life Sciences
AJMC®
All rights reserved.